...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

The cone of silence again from ZEL/ZCC management, i hope it means a deal at some point or an IPO, My guess is a partnership deal with Pfizer the obvious chice as they are already in bed with them, you never know it could be  another BP  waiting in the wings,  Something has to give a some point whether managment is waiting for the TLD from  the BOM trial to have more leverage or maybe that was the whole point , Having  a BP buy the whole enchilida  RVX and ZCC together,, who knows.... GLTA

Share
New Message
Please login to post a reply